Global Coronary Intravascular Lithotripsy Device Market Size, Share & Trends Analysis | Global | 2026-2032

Global Intravascular Lithotripsy Device Market Report

By iData Research - 50 pages - 5 charts, 20 figures

Executive Summary

The global intravascular lithotripsy device market was valued at over $1.9 billion in 2025 and is expected to grow at a CAGR of 6.0% to reach nearly $2.9 billion over the forecast period. Growth is supported by increasing demand for effective calcium modification technologies in complex coronary interventions.
This report follows the same structured methodology as the attached example, combining unit sales, average selling prices and procedure-based modeling to quantify market size and growth trends .
Intravascular lithotripsy devices are catheter-based systems that deliver sonic pressure waves inside coronary arteries to fracture calcified plaque. This allows improved vessel compliance and more effective stent deployment in heavily calcified lesions.
While adoption in North America has reached a more mature stage, global uptake remains uneven. Reimbursement limitations, high procedural costs and the need for additional long-term clinical evidence continue to influence adoption in emerging and cost-sensitive regions.

Market Overview

The global intravascular lithotripsy device market includes systems designed to treat calcified coronary lesions through the use of localized sonic pressure waves. These devices are used during percutaneous coronary interventions to improve lesion preparation prior to stent placement.
IVL has emerged as an alternative to traditional plaque modification techniques such as atherectomy and specialty balloons. Its ability to fracture calcium while minimizing vessel trauma has made it a preferred option in certain complex cases.
The market is characterized by a strong clinical foundation supported by trial data and real-world evidence. Studies have demonstrated consistent procedural success, effective calcium disruption and favorable safety outcomes, contributing to growing physician confidence.
Despite these advantages, adoption varies significantly across regions. Developed markets have seen faster integration into clinical practice, while emerging markets are progressing more gradually due to cost constraints and reimbursement challenges.

Market Drivers

The strong clinical performance of IVL devices is one of the primary drivers of market growth. Data from major clinical trials and registries, including the DISRUPT CAD series, have consistently demonstrated high procedural success rates, reliable calcium modification and low complication rates. These outcomes have strengthened physician confidence and supported broader clinical adoption.
The rising prevalence of coronary artery disease is another key factor. As global populations age and the incidence of conditions such as diabetes, hypertension and chronic kidney disease increases, the number of patients with calcified coronary lesions continues to grow. These complex cases often require advanced plaque modification technologies, creating sustained demand for IVL.
Expanding global availability is also contributing to market growth. Regulatory approvals across major regions, including North America, Europe, Japan and China, are increasing access to IVL technology. As additional clinical data becomes available and reimbursement pathways evolve, adoption is expected to expand further into new markets.

Market Limiters

High device costs remain one of the most significant barriers to IVL adoption. IVL balloons are more expensive than conventional angioplasty balloons and may also exceed the cost of some atherectomy devices. In cost-sensitive healthcare systems, this price difference limits usage to the most complex cases.
Competition from established technologies also affects market growth. Rotational and orbital atherectomy devices, as well as specialty balloons, remain widely used and are familiar to many physicians. In cases where IVL does not offer a clear advantage, clinicians may prefer to rely on these established alternatives.
Limited long-term clinical data presents another challenge. While short- and mid-term outcomes have been favorable, long-term comparative data is still developing. Some physicians may delay adopting IVL as a standard approach until additional evidence becomes available.
Reimbursement variability further impacts adoption. In many regions, reimbursement frameworks have not yet fully adapted to support routine IVL use, slowing market expansion outside of well-established healthcare systems.

Market Coverage and Data Scope

Quantitative Coverage
Market size, market shares, market forecasts, growth rates, units sold and average selling prices.
Qualitative Coverage
Market trends, market limiters, competitive analysis, mergers and acquisitions, company profiles, product portfolios and technology developments.
Time Frame
Base year 2025, historical data to 2022 and forecasts through 2032.
Data Types Included
Unit sales, average selling prices, procedure numbers, market size and growth trends.

Markets Covered and Segmentation

The Global Intravascular Lithotripsy Device Market includes catheter-based IVL systems used in coronary interventions.
Each segment is analyzed by unit volume, average selling price and total market value. Forecasts and historical data provide a comprehensive view of market performance.
Although the market is relatively focused compared to broader interventional cardiology segments, its importance continues to grow as calcified lesion treatment becomes more common.

Competitive Analysis

Shockwave Medical is the leading company in the IVL device market, maintaining a dominant global position. As the first company to commercialize IVL technology, Shockwave has established a strong clinical and commercial foundation. The high barriers to entry associated with IVL development, including regulatory requirements and capital investment, are expected to support its continued leadership.
MicroPort represents a notable competitor, particularly within the Asia-Pacific region. Following regulatory approval of its IVL system in China in 2025, the company is positioned to compete in regional markets where domestic manufacturing and pricing advantages are important. However, its global presence remains limited compared to Shockwave.
The competitive landscape is currently concentrated, with few companies operating at scale. Market dynamics are shaped by clinical evidence, regulatory approvals and the ability to support global distribution and physician training.
As the market evolves, competition may increase as additional companies enter the space or expand their portfolios. However, high development costs and the need for extensive clinical validation are expected to limit rapid changes in market share.

Technology and Practice Trends

The adoption of IVL reflects a broader shift toward safer and more predictable plaque modification techniques. Unlike traditional approaches, IVL delivers energy in a controlled manner that minimizes damage to surrounding tissue while effectively treating calcified lesions.
Integration with existing interventional workflows is also a key trend. IVL systems are designed to be used alongside standard angioplasty and stenting procedures, allowing physicians to incorporate the technology without significant changes to procedural protocols.
There is also increasing interest in combining IVL with other technologies. In some cases, IVL is used in conjunction with specialty balloons or stents to optimize outcomes in complex lesions.
As clinical experience grows, IVL is expected to become more standardized within treatment algorithms. Ongoing research and long-term data will play an important role in defining its role relative to other plaque modification techniques.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Deliverables

50 pages of detailed narrative analysis, tables and forecasts.
5 charts and 20 figures illustrating market segmentation and performance metrics.

Methodology Appendix and Acronym Glossary
explaining all data definitions and modeling assumptions.
Licensing options include single-user, site and enterprise.

Why This Report

What is driving growth in the intravascular lithotripsy device market?
How does IVL compare to atherectomy and other plaque modification technologies?
Which regions are adopting IVL most rapidly and why?
What are the key cost and reimbursement challenges affecting adoption?
How are clinical outcomes influencing physician decision-making?
Which companies lead the market and what strategies are they using to maintain their position?
What risks could impact market growth over the forecast period?
How will expanding clinical data influence long-term adoption?
The Global Intravascular Lithotripsy Device Market Report from iData Research answers these questions through detailed modeling, competitive analysis and procedure-based forecasting. It provides the insights needed to understand this evolving segment and identify growth opportunities.

About iData Research

iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC. Show more